Adiposity-related inflammation: Effects of pregnancy

Obesity

Volumn 21, Issue 1, 2013, Pages E124-E130

  Friis, Camilla M ^a   Roland, Marie C Paasche ^a   Godang, Kristin ^a   Ueland, Thor ^a,b   Tanbo, Tom ^a,c   Bollerslev, Jens ^a,c   Henriksen, Tore ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; COHORT ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL OBESITY; NORWAY; PREGNANCY; PREGNANT WOMAN; UNIVERSITY HOSPITAL; UPREGULATION;

EID: 84876226063     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20120     Document Type: Article

References (40)

1. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006;27:399-404. (Pubitemid 44216188)
2. Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 2007;29:151-162. (Pubitemid 47596394)
3. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80-86. (Pubitemid 28394477)
4. Brewster JA, Orsi NM, Gopichandran N, McShane P, Ekbote UV, Walker JJ. Gestational effects on host inflammatory response in normal and pre-eclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 2008;140:21-26.
5. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953-966.
6. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Practice Res Clin Endocrinol Metab 2005;19:547-566. (Pubitemid 41823815)
7. Yu CK, Teoh TG, Robinson S. Obesity in pregnancy. BJOG 2006;113:1117-1125. (Pubitemid 44401204)
8. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30(Suppl A):S38-S42.
9. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005;162:1198-1206. (Pubitemid 41785914)
10. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26:819-824. (Pubitemid 36929349)
11. Curry AE, Vogel I, Skogstrand K, et al. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J Reprod Immunol 2008;77:152-160. (Pubitemid 351335084)
12. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007;92:969-975. (Pubitemid 46465671)
13. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231-4237.
14. Voldner N, Froslie KF, Bo K, et al. Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Acta Obstet Gynecol Scand 2008;87:423-429. (Pubitemid 351481706)
15. Friis CM, Froøslie KF, Roøislien J, et al. The interleukins IL-6 and IL-1Ra: a mediating role in the associations between BMI and birth weight? J Dev Orig Health Dis 2010;1:310-318.
16. Wu TL, Tsao KC, Chang CP, Li CN, Sun CF, Wu JT. Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta 2002;322:163-168. (Pubitemid 34718077)
17. Froslie KF, Godang K, Bollerslev J, et al. Correction of an unexpected increasing trend in glucose measurements during 7years recruitment to a cohort study. Clin Biochem 2011;44:1483-1486.
18. Devaraj S, O'Keefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 2005; 90:4549-4554. (Pubitemid 41159341)
19. Hauguel-de MS, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006;27:794-798. (Pubitemid 43947814)
20. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007;29:95-113. (Pubitemid 47603024)
21. Larsson A, Palm M, Hansson LO, Basu S, Axelsson O. Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand 2008;87: 1084-1088.
22. Hwang HS, Kwon JY, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2007;98:105-109. (Pubitemid 47044931)
23. Belo L, Santos-Silva A, Rocha S, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;123:46-51. (Pubitemid 41563092)
24. Khoury J, Henriksen T, Seljeflot I, Morkrid L, Froslie KF, Tonstad S. Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study. BJOG 2007;114: 279-288.
25. Freeman DJ, McManus F, Brown EA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004;44:708-714. (Pubitemid 39435242)
26. Ostensen M, Forger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005;64: 839-844. (Pubitemid 40733905)
27. Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1994;57:149-155.
28. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526. (Pubitemid 46588416)
29. Fernandez-Real JM, Broch M, Ricart W, et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998;47: 1757-1762. (Pubitemid 28476250)
30. Kupferminc MJ, Peaceman AM, Aderka D, et al. Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. Am J Obstet Gynecol 1995;173(3 Pt 1):900-905.
31. Opsjon SL, Novick D, Wathen NC, Cope AP, Wallach D, Aderka D. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995;29:119-134.
32. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators Inflamm 1998;7:69-72. (Pubitemid 28238116)
33. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505-2512. (Pubitemid 32545699)
34. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003;88:3507-3512. (Pubitemid 37034486)
35. Cancello R, Clement K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006;113:1141-1147. (Pubitemid 44401207)
36. Juge-Aubry CE, Somm E, Giusti V, et al. Adipose tissue is a major source of interleukin- 1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003;52:1104-1110. (Pubitemid 36523343)
37. Juge-Aubry CE, Somm E, Pernin A, et al. Adipose tissue is a regulated source of interleukin-10. Cytokine 2005;29:270-274. (Pubitemid 40320927)
38. Madan JC, Davis JM, Craig WY, et al. Maternal obesity and markers of inflammation in pregnancy. Cytokine 2009;47:61-64.
39. Vega-Sanchez R, Barajas-Vega HA, Rozada G, Espejel-Nunez A, Beltran-Montoya J, Vadillo-Ortega F. Association between adiposity and inflammatory markers in maternal and fetal blood in a group of Mexican pregnant women. Br J Nutr 2010; 104:1735-1739.
40. Kac G, Dos S, V, Schlussel MM, Moura AS. C-reactive protein and hormones but not IL-6 are associated to body mass index in first trimester of pregnancy. Arch Gynecol Obstet 2011;284:567-573.